Avemar is an all-natural, clinically proven, dietary supplement for cancer patients. Medical experts recognize Avemar as an effective supportive cancer treatment and recommend complementing the diet of concerned patients with Avemar. Scientific studies showed that Avemar also enhances the efficacy of conventional oncological treatments (surgery, radio-, chemo- and immunotherapy). With regular intake of Avemar, patients can relish a better quality of life and can enjoy a better lifestyle. Avemar is available in granulate and film-coated tablet form.
The active ingredient is Avemar pulvis, an all-natural compound made from fermented wheat germ extract using patented biotechnological processes. Since the invention of Avemar pulvis significant research has been undertaken - not only in the laboratory, but in test animals and human cancer patients as well. Numerous scientific studies have been conducted to study its safety profile and its effectiveness, including in vitro, in vivo and human clinical research. Over 100 reports have been written for presentation or publication since 1998, and over 33 peer-reviewed scientific papers are currently accessible at PubMed database. All scientific publications are accessible at the official Avemar Research website.
Avemar has been registered as “dietary food for special medical purposes for cancer patients” since 2002. Avemar also gained the NutrAward for the “Best New Product of the Year” in California, USA in 2006.
For more information about recommended dosage and application please click here!
Avemar pulvis, the active ingredient of the Avemar products, is made of fermented wheat germ. Wheat germ can be subjected to fermentation with Saccharomyces cerevisiae (baker's yeast) to yield the important benzoquinones: 2,6‑dimethoxy-benzoquinone (DMBQ) and 2-methoxy-benzoquinone. These benzoquinones are present in unfermented wheat germ as glycosides and the yeast glycosidase activity present during fermentation leads to release of the benzoquinones as aglycones. After fermentation the aqueous extract of wheat germ is decanted, and the product is spray-dried, homogenized, encapsulated, and formulated. The dried fermented wheat germ extract is standardized to contain methoxy-substituted benzoquinones (2-methoxy-benzoquinone and 2,6‑DMBQ) at a concentration of 0.04%.
Since the invention of Avemar pulvis significant research has been undertaken - not only in the laboratory, but in test animals and human cancer patients as well.
Avemar is all natural
Wheat germ, both fermented and unfermented, has been a part of the human diet for millennia with no indication that it poses any health hazards. Avemar is produced from wheat germ. A loaf of whole-wheat bread containing about 2 cups of whole-wheat flour (∼270 g) includes about 7 g of wheat germ. Wheat germ is also used as an ingredient in a wide variety of foods formulated to provide advantageous nutritional characteristics without any adverse effects.
The fermented wheat germ in Avemar pulvis is substantially equivalent to the fermented wheat germ found in whole-wheat food. Historically safe consumption of whole-wheat products also provides strong evidence of the safety of Avemar pulvis for its intended use.
Avemar is completely safe, and can be used in any stage of the malignant disease. Its toxicological status was tested, and it has also been reviewed for safety in the USA. In the opinion of the independent panel of medical, food safety, and toxicology experts that confirmed Avemar's GRAS (Generally Recognized as Safe) status in accordance with FDA regulations:
"Avemar has the toxicological profile of bread."
Avemar pulvis is a chemically well-characterized substance produced from food-grade starting materials that have a long history of use in the European Union and worldwide. In a granulate and film‑coated tablet form Avemar has been marketed over the counter in numerous countries for several years with no indication of adverse effects.
Please click here to read the Safety studies regarding a standardized extract of fermented wheat germ